Net cash used for operating activities (USD, millions)

Net cash provided by (used for) investing activities (USD, millions)

Net cash used for financing activities (USD, millions)

Effect of exchange rate changes on cash, cash equivalents and restricted cash (USD, millions)

Net decrease in cash, cash equivalents and restricted cash (USD, millions)

Additions to property, plant and equipment (USD, millions)

Proceeds from sale-leaseback transactions (USD, millions)

Proceeds from sale of other assets (USD, millions)

Business, investment and asset acquisitions, net of cash acquired (USD, millions)

Other cash flow from investing activities (USD, millions)

Net change in short-term debt with maturities of 3 months or less (USD, millions)

Proceeds from debt (USD, millions)

Payments of debt (USD, millions)

Treasury stock purchases (USD, millions)

Cash dividends paid (USD, millions)

Other cash flow from financing activities (USD, millions)

Cash, cash equivalents and restricted cash at beginning of period (USD, millions)

Cash, cash equivalents and restricted cash at end of period (USD, millions)

c3b7c581781fbf565d9d03307ba3d98eedf1bfe7f02c5710d9796b9d18ccb972

Cash and cash equivalents (USD, millions)

Marketable securities (USD, millions)

Accounts receivable, net (USD, millions)

Inventories (USD, millions)

Other current assets (USD, millions)

Total current assets (USD, millions)

Property, plant and equipment, net (USD, millions)

Operating lease right-of-use assets (USD, millions)

Goodwill (USD, millions)

Intangible assets, net (USD, millions)

Equity method investments (see Note 4) (USD, millions)

Other non-current assets (USD, millions)

Total non-current assets (USD, millions)

Total assets (USD, millions)

Short-term debt (USD, millions)

Trade accounts payable (see Note 13) (USD, millions)

Operating lease obligations (USD, millions)

Accrued expenses and other liabilities (USD, millions)

Income taxes (USD, millions)

Total current liabilities (USD, millions)

Long-term debt (USD, millions)

Deferred income taxes (USD, millions)

Accrued litigation obligations (USD, millions)

Other non-current liabilities (USD, millions)

Total non-current liabilities (USD, millions)

Redeemable non-controlling interests (USD, millions)

Total equity (USD, millions)

Total liabilities, redeemable non-controlling interests and equity (USD, millions)

58438c0bfc509b961118b8272157ddc587ace918f4c297f330913aa7c594c04a

Sales (USD, millions)

Cost of Sales (USD, millions)

Gross Profit (USD, millions)

Selling, General and Administrative Expenses (USD, millions)

Impairment of Goodwill (USD, millions)

Equity Earnings in Cencora (USD, millions)

Operating (Loss) Income (USD, millions)

Other Income (Expense), Net (USD, millions)

(Loss) Earnings Before Interest and Income Tax (Benefit) Provision (USD, millions)

Interest Expense, Net (USD, millions)

(Loss) Earnings Before Income Tax (Benefit) Provision (USD, millions)

Income Tax (Benefit) Provision (USD, millions)

Post-tax Earnings from Other Equity Method Investments (USD, millions)

Net (Loss) Earnings (USD, millions)

Net Loss Attributable to Non-controlling Interests (USD, millions)

Net (Loss) Earnings Attributable to Walgreens Boots Alliance, Inc. (USD, millions)

Basic Net (Loss) Earnings per Common Share (USD)

Diluted Net (Loss) Earnings per Common Share (USD)

0c3e8d6418ddc1be9cff75d3a7a4d602e3647edd7f557d472b5ea5ca6135ff9d

0480bfde5e1deea104ee6cb5ab056b0140f3479480b6f8d6a6e46c717b0bbbe4

03a14739842c65f86909baf81399ea1ea583eda3b15e8366b0d1ddda851b09e0

77d6565fac9407b32148f1467cedce636c1eb7715d4b9a7e1535935dc540ec98

U.S. Retail Pharmacy

International

- Germany

- United Kingdom

- Other

U.S. Healthcare

Walgreens Health

Corporate and Other

Pharmaceutical Wholesale

Eliminations

Total Revenue

5e0b2f700f1cabe39f4dcf33dd3c190dc7cd3bf14b3a614ecf872108f46476a3

- Pharmacy

- Retail

- Wholesale

03e863a77c16b64f54fedb3b4c2689ed831ae20219f8f3f4b1592f8ea82360dc

Walgreens Boots Alliance (WBA)

Financials